1,094
Views
2
CrossRef citations to date
0
Altmetric
Oncology

Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2− metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis

, , , , , , & show all
Pages 414-423 | Accepted 10 Dec 2015, Published online: 01 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ravi K. Goyal, Gebra Cuyun Carter, Saurabh P. Nagar, Emily Nash Smyth, Gregory L. Price, Rohan C. Parikh, Yu-Jing Huang, Li Li, Keith L. Davis & James A. Kaye. (2021) Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2– metastatic breast cancer in the United States. Expert Review of Pharmacoeconomics & Outcomes Research 21:4, pages 699-710.
Read now

Articles from other publishers (1)

P. H. Dufton, M. F. Gerdtz, R. Jarden & M. Krishnasamy. (2022) Methodological approaches to measuring the incidence of unplanned emergency department presentations by cancer patients receiving systemic anti-cancer therapy: a systematic review. BMC Medical Research Methodology 22:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.